---
title: Empirical antibiotics
section: Acute respiratory failure
keywords:
  - community-acquired pneumonia
  - nosocomial pneumonia
  - antibiotics
  - amoxicillin
  - amoxicillin-clavulanate
  - doxycycline
  - azithromycin
  - ceftriaxone
  - cefotaxime
  - piperacillin-tazobactam
  - meropenem
  - levofloxacin
---

# Empirical antibiotics

## Community-acquired pneumonia

- For severe pneumonia
  - **3rd generation cephalosporin** - ceftriaxone, cefotaxime
  - **Macrolide** - erythromycin, azithromycin, clarithromycin
- For high risk of multidrug-resistant organisms
  - **Anti-pseudomonal cephalosporin / carbapenem / BLBLI**
  - **Macrolide**

## Nosocomial pneumonia

Same as community-acquired pneumonia, but with additional options for resistant organisms:

- Recent antibiotic use within 90 days or high risk of mortality
  - **Antipseudomonal carbapenem** - meropenem, imipenem
  - **MRSA coverage** - Linezolid or vancomycin
- Low risk of mortality
  - **Antipseudomonal cephalosporin / BLBLI** - cefepime, piperacillin-tazobactam
